ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
생리통 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연간 평균 성장률(CAGR) 6.2%로 성장할 전망이며, 280억 달러로 성장이 예측됩니다. 예측 기간에 전망되는 성장은 노인 인구 확대, 자궁 내 피임기구의 사용 증가, 기술의 진보, 저침습 처치에 대한 기호 고조, 예방 헬스케어에 대한 주목 고조 등의 요인에 의해서 초래됩니다. 이 기간에 예상되는 주요 동향에는 치료 선택지의 발전, 지속 가능하고 친환경적인 치료에 대한 관심, 추가적인 기술의 진보, 호르몬 투여 방법 개선, 혁신적인 치료법 개발 등이 있습니다.
호르몬 균형 혼란의 유병률 증가는 미래의 생리통 시장의 성장을 가속할 것으로 예측됩니다. 호르몬 균형의 혼란은 체내 호르몬이 과잉 또는 부족해지면서 일어나며 체중의 변동, 기분의 변화, 피로, 생식에 관한 문제 등 다양한 건강 문제를 일으킵니다. 현대적인 라이프 스타일, 환경 영향, 병세 등의 요인이 이러한 불균형의 원인이 되고 있습니다. 식생활의 흐트러짐, 높은 수준의 스트레스, 운동 부족 등은 호르몬의 생성과 조절을 흐트러뜨릴 가능성이 있습니다. 호르몬 균형 혼란은 생리 주기의 정상적인 조절을 방해하고 자궁 환경에 영향을 줌으로써 생리 출혈증(생리 다량)을 유발할 수 있습니다. 예를 들어 2025년 1월 세계보건기구(WHO)는 다낭성 난소증후군을 중대한 공중보건상의 우려로 다루면서 매년 생식 연령 여성의 6-13%에 영향을 미치고 있습니다. 그 결과 호르몬 균형 혼란 발생이 증가하여 생리통 시장의 성장을 견인하고 있습니다.
생리통 시장의 주요 기업은 효과적이고 장기적인 치료 옵션을 제공하기 위해 호르몬 자궁 내 피임기구(IUD)와 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 호르몬성 IUD는 자궁 내에 장착하는 소형 T자형 기구로 황체호르몬을 방출해 자궁경관 점액을 진하게 하고 자궁내막을 얇게 만들어 배란을 억제함으로써 임신을 예방합니다. 예를 들어 2022년 10월 독일 제약회사 바이엘사는 피임 및 특발성 생리통 치료에 사용되는 호르몬성 IUD '밀레나'의 유럽 규제당국의 승인을 취득했습니다. 이 장치는 레보놀게스트렐을 지속적으로 방출하고 자궁내막을 얇게 만들어 경혈량을 줄이는데 도움을 주며, 매일 투약이나 수술이 필요 없이 생리 다량 출혈을 관리하는 실용적이고 장기적인 해결책을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 생리통 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 생리통 시장 : 성장률 분석
세계의 생리통 시장 실적 : 규모 및 성장(2019-2024년)
세계의 생리통 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 생리통 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 생리통 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
호르몬제
비호르몬제
세계의 생리통 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구
질
경피
자궁내
기타 투여 경로
세계의 생리통 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
소매 약국
병원 약국
온라인 약국
세계의 생리통 시장 : 호르몬제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
복합경구피임약(COC)
프로게스틴
고나도트로핀 방출 호르몬(GnRH) 작용제
레보놀 게스트렐 방출 자궁내 시스템(LNG-IUS)
다나졸
선택적 에스트로겐 수용체 조절제(SERM)
세계의 생리통 시장 : 비호르몬제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
비스테로이드성 항염증제(NSAID)
트라넥삼산
항선용약
철 보충제
허브 및 자연요법
제7장 지역별 및 국가별 분석
세계의 생리통 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 생리통 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
생리통 시장 : 경쟁 구도
생리통 시장 : 기업 프로파일
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer HealthCare Pharmaceuticals Inc.(a division of Bayer AG) : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Boston Scientific Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Johns Hopkins Health System Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Aegea Medical Inc.
Emory Healthcare Inc.
Hologic Inc.
Dr. Reddy's Laboratories Ltd.
Meril Life Sciences Pvt. Ltd.
ASKA Pharmaceutical Holdings Co. Ltd.
Ferring Pharmaceuticals Group
Minerva Infra Tech Private Limited
Roivant Sciences Ltd.
Xanodyne Pharmaceuticals Inc.
Pregna International Ltd.
HLL Lifecare Limited
Actiza Pharmaceutical Pvt. Ltd.
Wellona Pharma
OCON Healthcare Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
생리통 시장(2029년) : 새로운 기회를 제공하는 국가
생리통 시장(2029년) : 새로운 기회를 제공하는 부문
생리통 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Menorrhagia, also known as menorrhalgia, refers to excessively heavy or prolonged menstrual bleeding. It is characterized by menstrual cycles lasting longer than seven days or involving blood loss greater than 80 milliliters. This condition can result in fatigue, anemia, and discomfort. Menorrhagia may be caused by factors such as hormonal imbalances, uterine fibroids, polyps, or other underlying health issues.
The primary therapeutic options for menorrhagia are hormonal and non-hormonal agents. Hormonal treatments help manage menorrhagia by regulating hormones to reduce uterine contractions, control the growth of the endometrium, and alleviate both pain and bleeding. These medications can be administered through various methods, including oral, vaginal, transdermal, intrauterine, and other routes. They are available through various distribution channels, including retail pharmacies, hospital pharmacies, and online pharmacies.
The menorrhalgia market research report is one of a series of new reports from The Business Research Company that provides menorrhalgia market statistics, including the menorrhalgia industry global market size, regional shares, competitors with the menorrhalgia market share, detailed menorrhalgia market segments, market trends, and opportunities, and any further data you may need to thrive in the menorrhalgia industry. This menorrhalgia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The menorrhalgia market size has grown strongly in recent years. It will grow from $20.61 billion in 2024 to $21.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth observed in the historical period can be attributed to factors such as the rising incidence of hormonal imbalances, increased awareness about menorrhalgia, a higher prevalence of gynecological disorders, the growing incidence of endometrial cancer, and better availability of over-the-counter medications.
The menorrhalgia market size is expected to see strong growth in the next few years. It will grow to $28.00 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth projected for the forecast period is driven by factors such as the expanding geriatric population, an increase in the use of intrauterine devices, technological advancements, a growing preference for minimally invasive procedures, and a rising focus on preventive healthcare. Key trends expected during this period include advancements in treatment options, a focus on sustainable and eco-friendly therapies, further technological progress, improvements in hormone delivery methods, and the development of innovative treatment modalities.
The increasing prevalence of hormonal imbalances is expected to drive the growth of the menorrhagia market in the future. Hormonal imbalances occur when there is an excess or deficiency of hormones in the body, leading to various health issues such as weight fluctuations, mood changes, fatigue, and reproductive problems. Factors such as modern lifestyles, environmental influences, and medical conditions contribute to these imbalances. Poor diet, high stress levels, and lack of physical activity can disrupt hormone production and regulation. Hormonal imbalances can trigger menorrhagia (heavy menstrual bleeding) by interfering with the normal regulation of the menstrual cycle and impacting the uterine environment. For instance, in January 2025, the World Health Organization highlighted polycystic ovary syndrome as a significant public health concern, affecting 6-13% of women of reproductive age annually. Consequently, the increasing occurrence of hormonal imbalances is driving market growth for menorrhagia.
Leading companies in the menorrhagia market are focusing on the development of innovative solutions, such as hormonal intrauterine devices (IUDs), to provide effective and long-term treatment options. A hormonal IUD is a small, T-shaped device placed inside the uterus that releases progestin to prevent pregnancy by thickening cervical mucus, thinning the uterine lining, and inhibiting ovulation. For example, in October 2022, Bayer AG, a German pharmaceutical company, received regulatory approval in Europe for Mirena, a hormonal IUD used for contraception and the treatment of idiopathic menorrhagia. This device continuously releases levonorgestrel, helping to reduce menstrual blood loss by thinning the uterine lining and reducing menstrual flow, offering a practical, long-term solution for managing heavy menstrual bleeding without the need for daily medication or surgery.
In January 2025, Hologic Inc., a US-based health technology company, acquired Gynesonics Inc. for an undisclosed sum. This acquisition allows Hologic to expand its portfolio of minimally invasive solutions for treating uterine fibroids and heavy menstrual bleeding, enhancing healthcare options for women. Gynesonics Inc. is a US-based medical device company specializing in systems for treating menorrhagia.
Major players in the menorrhalgia market are AbbVie Inc., Bayer HealthCare Pharmaceuticals Inc. (a division of Bayer AG), Baxter International Inc., Boston Scientific Corporation, Johns Hopkins Health System Corporation, Aegea Medical Inc., Emory Healthcare Inc., Hologic Inc., Dr. Reddy's Laboratories Ltd., Meril Life Sciences Pvt. Ltd., ASKA Pharmaceutical Holdings Co. Ltd., Ferring Pharmaceuticals Group, Minerva Infra Tech Private Limited, Roivant Sciences Ltd., Xanodyne Pharmaceuticals Inc., Pregna International Ltd., HLL Lifecare Limited, Actiza Pharmaceutical Pvt. Ltd., Wellona Pharma, OCON Healthcare Ltd.
North America was the largest region in the menorrhalgia market in 2024. The regions covered in menorrhalgia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the menorrhalgia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The menorrhalgia market consists of revenues earned by entities by providing services such as medical consultation, diagnostic testing, and medication management. The market value includes the value of related goods sold by the service provider or included within the service offering. The menorrhagia market also consists of sales of products including medications, medical devices, and supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Menorrhalgia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on menorrhalgia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for menorrhalgia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menorrhalgia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Therapeutics: Hormonal Agents; Non-Hormonal Agents
2) By Route Of Administration: Oral; Vaginal; Transdermal; Intrauterine; Other Route Of Administrations
3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies
2) By Non-Hormonal Agents: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Tranexamic Acid; Antifibrinolytics; Iron Supplements; Herbal And Natural Remedies
Companies Mentioned: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc. (a division of Bayer AG); Baxter International Inc.; Boston Scientific Corporation; Johns Hopkins Health System Corporation
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Menorrhalgia Market Characteristics
3. Menorrhalgia Market Trends And Strategies
4. Menorrhalgia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Menorrhalgia Growth Analysis And Strategic Analysis Framework
5.1. Global Menorrhalgia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Menorrhalgia Market Growth Rate Analysis
5.4. Global Menorrhalgia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Menorrhalgia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Menorrhalgia Total Addressable Market (TAM)
6. Menorrhalgia Market Segmentation
6.1. Global Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal Agents
Non-Hormonal Agents
6.2. Global Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Vaginal
Transdermal
Intrauterine
Other Route Of Administrations
6.3. Global Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
6.4. Global Menorrhalgia Market, Sub-Segmentation Of Hormonal Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combined Oral Contraceptives (COCs)
Progestins
Gonadotropin-Releasing Hormone (GnRH) Agonists
Levonorgestrel-Releasing Intrauterine Systems (LNG-IUS)
Danazol
Selective Estrogen Receptor Modulators (SERMs)
6.5. Global Menorrhalgia Market, Sub-Segmentation Of Non-Hormonal Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Tranexamic Acid
Antifibrinolytics
Iron Supplements
Herbal And Natural Remedies
7. Menorrhalgia Market Regional And Country Analysis
7.1. Global Menorrhalgia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Menorrhalgia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Menorrhalgia Market
8.1. Asia-Pacific Menorrhalgia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Menorrhalgia Market
9.1. China Menorrhalgia Market Overview
9.2. China Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Menorrhalgia Market
10.1. India Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Menorrhalgia Market
11.1. Japan Menorrhalgia Market Overview
11.2. Japan Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Menorrhalgia Market
12.1. Australia Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Menorrhalgia Market
13.1. Indonesia Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Menorrhalgia Market
14.1. South Korea Menorrhalgia Market Overview
14.2. South Korea Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Menorrhalgia Market
15.1. Western Europe Menorrhalgia Market Overview
15.2. Western Europe Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Menorrhalgia Market
16.1. UK Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Menorrhalgia Market
17.1. Germany Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Menorrhalgia Market
18.1. France Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Menorrhalgia Market
19.1. Italy Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Menorrhalgia Market
20.1. Spain Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Menorrhalgia Market
21.1. Eastern Europe Menorrhalgia Market Overview
21.2. Eastern Europe Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Menorrhalgia Market
22.1. Russia Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Menorrhalgia Market
23.1. North America Menorrhalgia Market Overview
23.2. North America Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Menorrhalgia Market
24.1. USA Menorrhalgia Market Overview
24.2. USA Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Menorrhalgia Market
25.1. Canada Menorrhalgia Market Overview
25.2. Canada Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Menorrhalgia Market
26.1. South America Menorrhalgia Market Overview
26.2. South America Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Menorrhalgia Market
27.1. Brazil Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Menorrhalgia Market
28.1. Middle East Menorrhalgia Market Overview
28.2. Middle East Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Menorrhalgia Market
29.1. Africa Menorrhalgia Market Overview
29.2. Africa Menorrhalgia Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Menorrhalgia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Menorrhalgia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Menorrhalgia Market Competitive Landscape And Company Profiles
30.1. Menorrhalgia Market Competitive Landscape
30.2. Menorrhalgia Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bayer HealthCare Pharmaceuticals Inc. (a division of Bayer AG) Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Johns Hopkins Health System Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Menorrhalgia Market Other Major And Innovative Companies
31.1. Aegea Medical Inc.
31.2. Emory Healthcare Inc.
31.3. Hologic Inc.
31.4. Dr. Reddy's Laboratories Ltd.
31.5. Meril Life Sciences Pvt. Ltd.
31.6. ASKA Pharmaceutical Holdings Co. Ltd.
31.7. Ferring Pharmaceuticals Group
31.8. Minerva Infra Tech Private Limited
31.9. Roivant Sciences Ltd.
31.10. Xanodyne Pharmaceuticals Inc.
31.11. Pregna International Ltd.
31.12. HLL Lifecare Limited
31.13. Actiza Pharmaceutical Pvt. Ltd.
31.14. Wellona Pharma
31.15. OCON Healthcare Ltd.
32. Global Menorrhalgia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Menorrhalgia Market
34. Recent Developments In The Menorrhalgia Market
35. Menorrhalgia Market High Potential Countries, Segments and Strategies
35.1 Menorrhalgia Market In 2029 - Countries Offering Most New Opportunities
35.2 Menorrhalgia Market In 2029 - Segments Offering Most New Opportunities
35.3 Menorrhalgia Market In 2029 - Growth Strategies
